Skip to main content

Table 2 Stability test of pilocarpine solution filled in a Hybripack® tube

From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life

Time (day) Pilocarpine concentration (μg/mL) a Residual (%)
0 0.56 ± 0.03 100
3 0.52 ± 0.02 92.8
7 0.59 ± 0.01 105.3
14 0.55 ± 0.02 98.4
28 0.55 ± 0.01 98.6
  1. a: Data are expressed as means ± SD (n = 3)